ロード中...
A real‐world, observational study of weekly exenatide added to basal insulin in patients with type 2 diabetes mellitus (NCT02895672)
AIM: This is a pre‐post observational study from an endocrinology ambulatory care practice which assessed the effectiveness and safety following the addition of a glucagon‐like peptide‐1 (GLP‐1) agonist, weekly exenatide (Bydureon), to basal insulin therapy in patients with type 2 diabetes mellitus...
保存先:
| 出版年: | Endocrinol Diabetes Metab |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360919/ https://ncbi.nlm.nih.gov/pubmed/30815541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|